{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:11:37Z","timestamp":1790349097895,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"EU\/EFPIA\/(Associated Partner) Innovative Medicines Initiative (2) Joint Undertaking","award":["115568"],"award-info":[{"award-number":["115568"]}]},{"name":"European Union\u2019s Seventh Framework Programme","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}]},{"name":"INMiND","award":["HEALTH-F2-2011-278850 TP21"],"award-info":[{"award-number":["HEALTH-F2-2011-278850 TP21"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["KFO177, TP4"],"award-info":[{"award-number":["KFO177, TP4"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13195-018-0353-3","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T17:27:36Z","timestamp":1519666056000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Characterization and clinical use of inflammatory cerebrospinal fluid protein markers in Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"10","author":[{"given":"Frederic","family":"Brosseron","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Trasch\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine N.","family":"Widmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus P.","family":"Kummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Tacik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Santarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Jessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Heneka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"issue":"3","key":"353_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ni.3102","volume":"16","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Golenbock DT, Latz E. Innate immunity in Alzheimer\u2019s disease. Nat Immunol. 2015;16(3):229\u201336.","journal-title":"Nat Immunol."},{"issue":"6","key":"353_CR2","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro V, Edison P. Neuroinflammation in Alzheimer\u2019s disease: current evidence and future directions. Alzheimers Dement. 2016;12(6):719\u201332.","journal-title":"Alzheimers Dement."},{"key":"353_CR3","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.neurobiolaging.2016.02.034","volume":"52","author":"N Mattsson","year":"2017","unstructured":"Mattsson N, L\u00f6nneborg A, Boccardi M, Blennow K, Hansson O, Geneva Task Force for the Roadmap of Alzheimer\u2019s Biomarkers. Clinical validity of cerebrospinal fluid A\u03b242, tau, and phospho-tau as biomarkers for Alzheimer\u2019s disease in the context of a structured 5-phase development framework. Neurobiol Aging. 2017;52:196\u2013213.","journal-title":"Neurobiol Aging"},{"issue":"9","key":"353_CR4","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.biopsych.2013.11.032","volume":"75","author":"O Harari","year":"2014","unstructured":"Harari O, Cruchaga C, Kauwe JS, Ainscough BJ, Bales K, Pickering EH, Bertelsen S, Fagan AM, Holtzman DM, Morris JC, et al. Phosphorylated tau-A\u03b242 ratio as a continuous trait for biomarker discovery for early-stage Alzheimer\u2019s disease in multiplex immunoassay panels of cerebrospinal fluid. Biol Psychiatry. 2014;75(9):723\u201331.","journal-title":"Biol Psychiatry."},{"issue":"2","key":"353_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12035-014-8657-1","volume":"50","author":"F Brosseron","year":"2014","unstructured":"Brosseron F, Krauthausen M, Kummer M, Heneka MT. Body fluid cytokine levels in mild cognitive impairment and Alzheimer\u2019s disease: a comparative overview. Mol Neurobiol. 2014;50(2):534\u201344.","journal-title":"Mol Neurobiol."},{"issue":"10","key":"353_CR6","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.biopsych.2010.06.012","volume":"68","author":"W Swardfager","year":"2010","unstructured":"Swardfager W, Lanctot K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer\u2019s disease. Biol Psychiatry. 2010;68(10):930\u201341.","journal-title":"Biol Psychiatry."},{"key":"353_CR7","first-page":"e293","volume":"3","author":"N Mattsson","year":"2013","unstructured":"Mattsson N, Insel P, Nosheny R, Zetterberg H, Trojanowski JQ, Shaw LM, Tosun D, Weiner M. Alzheimer\u2019s Disease Neuroimaging Initiative. CSF protein biomarkers predicting longitudinal reduction of CSF \u03b2-amyloid42 in cognitively healthy elders. Transl. Psychiatry. 2013;3:e293.","journal-title":"Psychiatry."},{"key":"353_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.neurobiolaging.2015.10.021","volume":"38","author":"A Chen","year":"2016","unstructured":"Chen A, Oakley AE, Monteiro M, Tuomela K, Allan LM, Mukaetova-Ladinska EB, O\u2019Brien JT, Kalaria RN. Multiplex analyte assays to characterize different dementias: brain inflammatory cytokines in poststroke and other dementias. Neurobiol Aging. 2016;38:56\u201367.","journal-title":"Neurobiol Aging."},{"issue":"8","key":"353_CR9","doi-asserted-by":"publisher","first-page":"djv153","DOI":"10.1093\/jnci\/djv153","volume":"107","author":"R Simon","year":"2015","unstructured":"Simon R. Sensitivity, specificity, PPV, and NPV for predictive biomarkers. J Natl Cancer Inst. 2015;107(8):djv153.","journal-title":"J Natl Cancer Inst"},{"issue":"49","key":"353_CR10","doi-asserted-by":"publisher","first-page":"17824","DOI":"10.1523\/JNEUROSCI.1504-12.2012","volume":"32","author":"MP Kummer","year":"2012","unstructured":"Kummer MP, Vogl T, Axt D, Griep A, Vieira-Saecker A, Jessen F, Gelpi E, Roth J, Heneka MT. Mrp14 deficiency ameliorates amyloid \u03b2 burden by increasing microglial phagocytosis and modulation of amyloid precursor protein processing. J Neurosci. 2012;32(49):17824\u20139.","journal-title":"J Neurosci."},{"issue":"1","key":"353_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2047-9158-2-21","volume":"2","author":"Y Shen","year":"2013","unstructured":"Shen Y, Yang L, Li R. What does complement do in Alzheimer\u2019s disease? Old molecules with new insights. Transl Neurodegener. 2013;2(1):21.","journal-title":"Transl Neurodegener."},{"issue":"10","key":"353_CR12","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1007\/s10072-015-2274-2","volume":"36","author":"Y Lu","year":"2015","unstructured":"Lu Y, Liu W, Wang X. TREM2 variants and risk of Alzheimer\u2019s disease: a meta-analysis. Neurol Sci. 2015;36(10):1881\u20138.","journal-title":"Neurol Sci."},{"issue":"Pt 10","key":"353_CR13","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1093\/brain\/awv231","volume":"138","author":"VK Ramanan","year":"2015","unstructured":"Ramanan VK, Risacher SL, Nho K, Kim S, Shen L, McDonald BC, Yoder KK, Hutchins GD, West JD, Tallman EF, et al. GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer\u2019s disease implicates microglial activation gene IL1RAP. Brain. 2015;138(Pt 10):3076\u201388.","journal-title":"Brain."},{"issue":"10","key":"353_CR14","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/glia.22988","volume":"64","author":"PD Wes","year":"2016","unstructured":"Wes PD, Sayed FA, Bard F, Gan L. Targeting microglia for the treatment of Alzheimer\u2019s disease. Glia. 2016;64(10):1710\u201332.","journal-title":"Glia."},{"issue":"3","key":"353_CR15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res."},{"issue":"9","key":"353_CR16","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","volume":"39","author":"JC Morris","year":"1989","unstructured":"Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C. The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer\u2019s disease. Neurology. 1989;39(9):1159\u201365.","journal-title":"Neurology."},{"issue":"3","key":"353_CR17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/WAD.0b013e3181cfc78b","volume":"24","author":"E Grober","year":"2010","unstructured":"Grober E, Sanders AE, Hall C, Lipton RB. Free and cued selective reminding identifies very mild dementia in primary care. Alzheimer Dis Assoc Disord. 2010;24(3):284\u201390.","journal-title":"Alzheimer Dis Assoc Disord."},{"issue":"3","key":"353_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, et al. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):263\u20139.","journal-title":"Alzheimers Dement."},{"issue":"2","key":"353_CR19","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu CC, Liu CC, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9(2):106\u201318.","journal-title":"Nat Rev Neurol."},{"issue":"7339","key":"353_CR20","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1038\/471S19a","volume":"471","author":"V Brower","year":"2011","unstructured":"Brower V. Biomarkers: portents of malignancy. Nature. 2011;471(7339):S19\u201321.","journal-title":"Nature."},{"key":"353_CR21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.dadm.2015.12.003","volume":"3","author":"SE O\u2019Bryant","year":"2016","unstructured":"O\u2019Bryant SE, Lista S, Rissman RA, Edwards M, Zhang F, Hall J, Zetterberg H, Lovestone S, Gupta V, Graff-Radford N, et al. Comparing biological markers of Alzheimer\u2019s disease across blood fraction and platforms: Comparing apples to oranges. Alzheimers Dement (Amst). 2016;3:27\u201334.","journal-title":"Alzheimers Dement (Amst)."},{"issue":"4","key":"353_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/gerona\/gls187","volume":"68","author":"A Koyama","year":"2013","unstructured":"Koyama A, O\u2019Brien J, Weuve J, Blacker D, Metti AL, Yaffe K. The role of peripheral inflammatory markers in dementia and Alzheimer\u2019s disease: a meta-analysis. J Gerontol A Biol Sci Med Sci. 2013;68(4):433\u201340.","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"1","key":"353_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000442585","volume":"6","author":"Y Watanabe","year":"2016","unstructured":"Watanabe Y, Kitamura K, Nakamura K, Sanpei K, Wakasugi M, Yokoseki A, Onodera O, Ikeuchi T, Kuwano R, Momotsu T, et al. Elevated C-reactive protein is associated with cognitive decline in outpatients of a general hospital: the Project in Sado for Total Health (PROST). Dement Geriatr Cogn Dis Extra. 2016;6(1):10\u20139.","journal-title":"Dement Geriatr Cogn Dis Extra."},{"issue":"4","key":"353_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/aje\/kwg135","volume":"158","author":"W Koenig","year":"2003","unstructured":"Koenig W, Sund M, Fr\u00f6hlich M, L\u00f6wel H, Hutchinson WL, Pepys MB. Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987. Am J Epidemiol. 2003;158(4):357\u201364.","journal-title":"Am J Epidemiol."},{"issue":"11","key":"353_CR25","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.neurobiolaging.2008.01.014","volume":"30","author":"A Schuitemaker","year":"2009","unstructured":"Schuitemaker A, Dik MG, Veerhuis R, Scheltens P, Schoonenboom NS, Hack CE, Blankenstein MA, Jonker C. Inflammatory markers in AD and MCI patients with different biomarker profiles. Neurobiol Aging. 2009;30(11):1885\u20139.","journal-title":"Neurobiol Aging."},{"key":"353_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.bbi.2013.07.007","volume":"33","author":"D Lindqvist","year":"2013","unstructured":"Lindqvist D, Hall S, Surova Y, Nielsen HM, Janelidze S, Brundin L, Hansson O. Cerebrospinal fluid inflammatory markers in Parkinson\u2019s disease \u2013 associations with depression, fatigue, and cognitive impairment. Brain Behav Immun. 2013;33:183\u20139.","journal-title":"Brain Behav Immun."},{"key":"353_CR27","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/1742-2094-8-96","volume":"8","author":"EH Kok","year":"2011","unstructured":"Kok EH, Alanne-Kinnunen M, Isotalo K, Luoto T, Haikonen S, Goebeler S, Perola M, Hurme MA, Haapasalo H, Karhunen PJ. CRP gene variation affects early development of Alzheimer\u2019s disease-related plaques. J Neuroinflammation. 2011;8:96.","journal-title":"J Neuroinflammation."},{"issue":"3","key":"353_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1750-3639.2011.00539.x","volume":"22","author":"F Strang","year":"2012","unstructured":"Strang F, Scheichl A, Chen YC, Wang X, Htun NM, Bassler N, Eisenhardt SU, Habersberger J, Peter K. Amyloid plaques dissociate pentameric to monomeric C-reactive protein: a novel pathomechanism driving cortical inflammation in Alzheimer\u2019s disease? Brain Pathol. 2012;22(3):337\u201346.","journal-title":"Brain Pathol."},{"issue":"3","key":"353_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.neuint.2011.12.007","volume":"60","author":"BT Bi","year":"2012","unstructured":"Bi BT, Lin HB, Cheng YF, Zhou H, Lin T, Zhang MZ, Li TJ, Xu JP. Promotion of \u03b2-amyloid production by C-reactive protein and its implications in the early pathogenesis of Alzheimer\u2019s disease. Neurochem Int. 2012;60(3):257\u201366.","journal-title":"Neurochem Int."},{"key":"353_CR30","doi-asserted-by":"publisher","first-page":"13281","DOI":"10.1038\/srep13281","volume":"5","author":"M Slevin","year":"2015","unstructured":"Slevin M, Matou S, Zeinolabediny Y, Corpas R, Weston R, Liu D, Boras E, Di Napoli M, Petcu E, Sarroca S, et al. Monomeric C-reactive protein \u2013 a key molecule driving development of Alzheimer\u2019s disease associated with brain ischaemia? Sci Rep. 2015;5:13281.","journal-title":"Sci Rep."},{"issue":"3","key":"353_CR31","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.humimm.2010.01.008","volume":"71","author":"JA Hubacek","year":"2010","unstructured":"Hubacek JA, Peasey A, Pikhart H, Stavek P, Kubinova R, Marmot M, Bobak M. APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample. Hum Immunol. 2010;71(3):304\u20138.","journal-title":"Hum Immunol."},{"issue":"4","key":"353_CR32","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.3233\/JAD-2010-100888","volume":"22","author":"SD Mulder","year":"2010","unstructured":"Mulder SD, Hack CE, van der Flier WM, Scheltens P, Blankenstein MA, Veerhuis R. Evaluation of intrathecal serum amyloid P (SAP) and C-reactive protein (CRP) synthesis in Alzheimer\u2019s disease with the use of index values. J Alzheimers Dis. 2010;22(4):1073\u20139.","journal-title":"J Alzheimers Dis."},{"key":"353_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-015-0040-9","volume":"10","author":"MM Painter","year":"2015","unstructured":"Painter MM, Atagi Y, Liu CC, Rademakers R, Xu H, Fryer JD, Bu G. TREM2 in CNS homeostasis and neurodegenerative disease. Mol Neurodegener. 2015;10:43.","journal-title":"Mol Neurodegener."},{"issue":"7","key":"353_CR34","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.15252\/embr.201743922","volume":"18","author":"F Mazaheri","year":"2017","unstructured":"Mazaheri F, Snaidero N, Kleinberger G, Madore C, Daria A, Werner G, Krasemann S, Capell A, Trumbach D, Wurst W, et al. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury. EMBO Rep. 2017;18(7):1186\u201398.","journal-title":"EMBO Rep."},{"issue":"5","key":"353_CR35","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15252\/emmm.201506123","volume":"8","author":"M Su\u00e1rez-Calvet","year":"2016","unstructured":"Su\u00e1rez-Calvet M, Kleinberger G, Araque Caballero MA, Brendel M, Rominger A, Alcolea D, Fortea J, Lleo A, Blesa R, Gispert JD, et al. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers. EMBO Mol Med. 2016;8(5):466\u201376.","journal-title":"EMBO Mol Med."},{"key":"353_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13024-016-0071-x","volume":"11","author":"A Heslegrave","year":"2016","unstructured":"Heslegrave A, Heywood W, Paterson R, Magdalinou N, Svensson J, Johansson P, Ohrfelt A, Blennow K, Hardy J, Schott J, et al. Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer\u2019s disease. Mol Neurodegener. 2016;11:3.","journal-title":"Mol Neurodegener."},{"issue":"6","key":"353_CR37","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00401-016-1533-5","volume":"131","author":"L Piccio","year":"2016","unstructured":"Piccio L, Deming Y, Del-Aguila JL, Ghezzi L, Holtzman DM, Fagan AM, Fenoglio C, Galimberti D, Borroni B, Cruchaga C. Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status. Acta Neuropathol. 2016;131(6):925\u201333.","journal-title":"Acta Neuropathol."},{"issue":"369","key":"353_CR38","doi-asserted-by":"publisher","first-page":"369ra178","DOI":"10.1126\/scitranslmed.aag1767","volume":"8","author":"M Su\u00e1rez-Calvet","year":"2016","unstructured":"Su\u00e1rez-Calvet M, Araque Caballero MA, Kleinberger G, Bateman RJ, Fagan AM, Morris JC, Levin J, Danek A, Ewers M, Haass C, et al. Early changes in CSF sTREM2 in dominantly inherited Alzheimer\u2019s disease occur after amyloid deposition and neuronal injury. Sci Transl Med. 2016;8(369):369ra178.","journal-title":"Sci Transl Med"},{"issue":"12","key":"353_CR39","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/j.jalz.2016.06.005","volume":"12","author":"JD Gispert","year":"2016","unstructured":"Gispert JD, Su\u00e1rez-Calvet M, Monte GC, Tucholka A, Falcon C, Rojas S, Rami L, Sanchez-Valle R, Llado A, Kleinberger G, et al. Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer\u2019s disease. Alzheimers Dement. 2016;12(12):1259\u201372.","journal-title":"Alzheimers Dement."},{"issue":"3","key":"353_CR40","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.ajhg.2012.07.023","volume":"91","author":"AP Reiner","year":"2012","unstructured":"Reiner AP, Beleza S, Franceschini N, Auer PL, Robinson JG, Kooperberg C, Peters U, Tang H. Genome-wide association and population genetic analysis of C-reactive protein in African American and Hispanic American women. Am J Hum Genet. 2012;91(3):502\u201312.","journal-title":"Am J Hum Genet."},{"key":"353_CR41","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fnins.2017.00114","volume":"11","author":"Y Okita","year":"2017","unstructured":"Okita Y, Rcom-H\u2019cheo-Gauthier AN, Goulding M, Chung RS, Faller P, Pountney DL. Metallothionein, copper and alpha-synuclein in alpha-synucleinopathies. Front Neurosci. 2017;11:114.","journal-title":"Front Neurosci."},{"key":"353_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.brainres.2016.04.004","volume":"1647","author":"AD Gitler","year":"2016","unstructured":"Gitler AD, Tsuiji H. There has been an awakening: emerging mechanisms of C9orf72 mutations in FTD\/ALS. Brain Res. 2016;1647:19\u201329.","journal-title":"Brain Res."},{"issue":"2","key":"353_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","volume":"70","author":"RL Wasserstein","year":"2016","unstructured":"Wasserstein RL, Lazar NA. The ASA\u2019s statement on p-values: context, process, and purpose. Am Stat. 2016;70(2):129\u201333.","journal-title":"Am Stat."},{"key":"353_CR44","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.dadm.2016.05.005","volume":"3","author":"U Andreasson","year":"2016","unstructured":"Andreasson U, Blennow K, Zetterberg H. Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders. Alzheimers Dement (Amst). 2016;3:98\u2013102.","journal-title":"Alzheimers Dement (Amst)."},{"issue":"9","key":"353_CR45","doi-asserted-by":"publisher","first-page":"e1004606","DOI":"10.1371\/journal.pgen.1004606","volume":"10","author":"GW Beecham","year":"2014","unstructured":"Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ, Corneveaux JJ, Hardy J, Vonsattel JP, Younkin SG, et al. Genome-wide association meta-analysis of neuropathologic features of Alzheimer\u2019s disease and related dementias. PLoS Genet. 2014;10(9):e1004606.","journal-title":"PLoS Genet."},{"issue":"10","key":"353_CR46","doi-asserted-by":"publisher","first-page":"e1004758","DOI":"10.1371\/journal.pgen.1004758","volume":"10","author":"JS Kauwe","year":"2014","unstructured":"Kauwe JS, Bailey MH, Ridge PG, Perry R, Wadsworth ME, Hoyt KL, Staley LA, Karch CM, Harari O, Cruchaga C, et al. Genome-wide association study of CSF levels of 59 Alzheimer\u2019s disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation. PLoS Genet. 2014;10(10):e1004758.","journal-title":"PLoS Genet."}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-018-0353-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T18:20:35Z","timestamp":1660501235000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-018-0353-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["353"],"URL":"https:\/\/doi.org\/10.1186\/s13195-018-0353-3","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,26]]},"assertion":[{"value":"23 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent for research purposes was obtained according to local ethics committee regulations (University of Bonn Ethical Committee 279\/10).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable, because no individual subject\u2019s information or data was used in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. This work was not supported by industry funding.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"25"}}